AvnishBhatiaMD

Oncology • Philadelphia, PA

Assistant Professor, Medical Oncology, Jefferson Medical College-Thos Jefferson Univ

Join to view full profile

Dr. Bhatia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bhatia's full profile

Already have an account?

Office
8815 Germantown Ave
Ste 16
Philadelphia, PA 19118
Phone+1 215-242-1159

Fax+1 215-242-4020
Is this information wrong?

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2005 - 2008
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 2002 - 2005
Drexel University College of MedicineClass of 2002

Certifications & Licensure

NJ State Medical License 2017 - 2025
DE State Medical License 2017 - 2025
PA State Medical License 2008 - 2024
NY State Medical License 2005 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013

Clinical Trials

Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Start of enrollment: 2010 Sep 15
Terminated
Phase 3
A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer Start of enrollment: 2011 May 25
Active, not recruiting
Phase 2
Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide Start of enrollment: 2011 Nov 09
Completed
Phase 1, Phase 2
Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer Start of enrollment: 2013 Apr 25
Completed
Phase 2
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer Start of enrollment: 2014 Apr 01
Terminated
Phase 1, Phase 2
Join now to see all

Publications & Presentations

Abstracts/Posters

A Multidisciplinary Approach for Bone Metastases
M. Mori, C. Brus, A. Bhatia, T. Nishihori and R. Blum, Journal of Pain and Symptom Management, Boston, MA, 2/2/2010

Hospital Affiliations

Thomas Jefferson University HospitalPhiladelphia, Pennsylvania
Jefferson Health NortheastPhiladelphia, Pennsylvania